Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Arecor Therape Share News (AREC)
AREC Share
Price
AREC Share
News
AREC Share
Chat
AREC Share
Trades1
AREC
Live RNS
AREC Share
Charts
AREC Level 2
Console
AREC Live
Share Price
AREC Broker
Ratings
AREC Directors
Deals
AREC Financial
Diary
AREC
Fundamentals
AREC Short
Positions
AREC
Media
AREC Company
Research
AREC Company
Timeline
Share Price Information for Arecor Therape (AREC)
Last checked at -
Last checked at 
Intraday Arecor Therape Share Chart
Arecor Therape News
Arecor Therapeutics swings to annual profit; hails insulin product
(Alliance News) - Arecor Therapeutics PLC on Monday highlighted the advancement of its lead product AT278, which is ultra-rapid-acting insulin, as it ...
TRADING UPDATES: LPA to meet consensus; Aptamer raises GBP4.28 million
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
Arecor Therapeutics revenue falls after Tetris Pharma operations cease
(Alliance News) - Arecor Therapeutics PLC on Monday said revenue fell in 2025 due to the end of operations at Tetris Pharma.
REPEAT: Seeing Machines loss narrows; Hansard profit falls
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:
EARNINGS: Seeing machine loss narrows; Hansard profit falls
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:
LONDON MARKET MIDDAY: European stocks fade ahead of US data
(Alliance News) - European equities were lower on Thursday afternoon, with enthusiasm at a minimum ahead of US data in the afternoon.
AIM WINNERS & LOSERS: Proteome Sciences loss narrows but revenue falls
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.
Follow the stocks
